TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
VRXA

Veraxa Biotech AG

Healthcare · Biotechnology

1.10$ +0.0% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VRXA
Line item Q4 24 Q2 25 Q4 25
– -3.0% -1.7%
– -30.3% -26.2%
– -38.2% -51.3%
– +0.0% +0.0%
– -1.5% -1.5%
– +29.4% +38.9%
– +30.0% +99.9%
– +131.4% +23.0%
– -59.0% -223.9%
– – –
– +0.0% +0.0%

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?